Adrian Fowkes

Adrian Fowkes

Auto-generated profile, based on publicly available information

Adrian Fowkes

Lhasa Limited, Leeds, UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Chemistry & Biology
Verified
Journal Article
Open access
DEDaniel A. East
Daniel A. East
FFFrancesca Fagiani
Francesca Fagiani
JCJames Crosby
James Crosby
NGNikolaos D. Georgakopoulos
Nikolaos D. Georgakopoulos
Hélène Charlotte BertrandHélène Charlotte Bertrand
Hélène Charlotte Bertrand
MCMichelangelo Campanella
Michelangelo Campanella
Mitophagy is central to mitochondrial and cellular homeostasis and operates via the PINK1/Parkin pathway targeting mitochondria devoid of membrane potential (ΔΨm) to autophagosomes. Although mitophagy is recognized as a fundamental cellular process, selective pharmacologic modulators of mitophagy are almost nonexistent. We developed a compound that increases the expression and signaling of the autophagic adaptor molecule P62/SQSTM1 and forces mitochondria into autophagy. The compound, P62-mediated mitophagy inducer (PMI), activates mitophagy without recruiting Parkin or collapsing ΔΨm and retains activity in cells devoid of a fully functional PINK1/Parkin pathway. PMI drives mitochondria to a process of quality control without compromising the bio-energetic competence of the whole network while exposing just those organelles to be recycled. Thus, PMI circumvents the toxicity and some of the nonspecific effects associated with the abrupt dissipation of ΔΨm by ionophores routinely used to induce mitophagy and represents a prototype pharmacological tool to investigate the molecular mechanisms of mitophagy.

14 September 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Hélène Charlotte BertrandHélène Charlotte Bertrand
Hélène Charlotte Bertrand
MSMarjolein Schaap
Marjolein Schaap
LBLiam Baird
Liam Baird
NGNikolaos D. Georgakopoulos
Nikolaos D. Georgakopoulos
AFAdrian Fowkes
Adrian Fowkes
GWGeoff Wells
Geoff Wells

1 April 2020 in Reproductive Toxicology
Verified
Journal Article
Open access
JCJ.M. Clements
J.M. Clements
RHR.G. Hawkes
R.G. Hawkes
DJD. Jones
D. Jones
AAA. Adjei
A. Adjei
TCT. Chambers
T. Chambers
FSF. Sewell
F. Sewell
The framework for developmental toxicity testing has remained largely unchanged for over 50 years and although it remains invaluable in assessing potential risks in pregnancy, knowledge gaps exist, and some outcomes do not necessarily correlate with clinical experience. Advances in omics, in silico approaches and alternative assays are providing opportunities to enhance our understanding of embryo-fetal development and the prediction of potential risks associated with the use of medicines in pregnancy. A workshop organised by the Medicines and Healthcare products Regulatory Agency (MHRA), "Predicting the Safety of Medicines in Pregnancy - a New Era?", was attended by delegates representing regulatory authorities, academia, industry, patients, funding bodies and software developers to consider how to improve the quality of and access to nonclinical developmental toxicity data and how to use this data to better predict the safety of medicines in human pregnancy. The workshop delegates concluded that based on comparative data to date alternative methodologies are currently no more predictive than conventional methods and not qualified for use in regulatory submissions. To advance the development and qualification of alternative methodologies, there is a requirement for better coordinated multidisciplinary cross-sector interactions coupled with data sharing. Furthermore, a better understanding of human developmental biology and the incorporation of this knowledge into the development of alternative methodologies is essential to enhance the prediction of adverse outcomes for human development. The output of the workshop was a series of recommendations aimed at supporting multidisciplinary efforts to develop and validate these alternative methodologies.

22 January 2021 in Toxicology Research
Verified
Journal Article
Open access
PDF file
TBThomas Ball
Thomas Ball
CBChristopher G Barber
Christopher G Barber
ACAlex Nigel Cayley
Alex Nigel Cayley
MCMartyn L Chilton
Martyn L Chilton
RFRobert Foster
Robert Foster
JVJonathan D Vessey
Jonathan D Vessey
Adverse outcome pathways have shown themselves to be useful ways of understanding and expressing knowledge about sequences of events that lead to adverse outcomes (AOs) such as toxicity. In this paper we use the building blocks of adverse outcome pathways—namely key events (KEs) and key event relationships—to construct networks which can be used to make predictions of the likelihood of AOs. The networks of KEs are augmented by data from and knowledge about assays as well as by structure activity relationship predictions linking chemical classes to the observation of KEs. These inputs are combined within a reasoning framework to produce an information-rich display of the relevant knowledge and data and predictions of AOs both in the abstract case and for individual chemicals. Illustrative examples are given for skin sensitization, reprotoxicity and non-genotoxic carcinogenicity.

16 May 2006 in Acta Crystallographica Section C Crystal Structure Communications
Verified
Journal Article
Open access
PDF file
AFAdrian Fowkes
Adrian Fowkes
William HarrisonWilliam Harrison
William Harrison
The title compound, [La(NO3)(C6H15NO3)2](NO3)2, contains a network of [La(NO3)(C6H15NO3)2]2+ cations and nitrate counter-ions. The crystal packing is influenced by cation-to-anion O-H...O hydrogen bonds, resulting in a structure with one-dimensional character. The ten-coordinate La atom and a nitrate anion have site symmetry 2. The fact that triethanolamine can bind to such diverse cations as Li+ and La3+ militates against possible applications that require selective binding of ligand to metal.

1 June 2017 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
RHRachel Hemingway
Rachel Hemingway
AFAdrian Fowkes
Adrian Fowkes
RWRichard V. Williams
Richard V. Williams